Argyle Capital Management’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Sell
3,527
-12
-0.3% -$875 0.08% 128
2026
Q1
$231K Sell
3,539
-87
-2% -$6.46K 0.08% 132
2025
Q4
$287K Sell
3,626
-125
-3% -$9.57K 0.1% 123
2025
Q3
$274K Hold
3,751
0.09% 124
2025
Q2
$284K Sell
3,751
-405
-10% -$28.7K 0.1% 121
2025
Q1
$316K Sell
4,156
-12
-0.3% -$894 0.12% 116
2024
Q4
$275K Sell
4,168
-244
-6% -$17.1K 0.11% 116
2024
Q3
$308K Sell
4,412
-304
-6% -$18.3K 0.12% 110
2024
Q2
$249K Buy
+4,716
New +$286K 0.1% 117

Other funds holding SOLV

Argyle Capital Management's SOLV Position: Q2 2026 in Review

Argyle Capital Management reduced its Solventum (SOLV) stake by 0.34% in Q2 2026, selling an estimated $875 and leaving 3,527 shares worth $272K. The position accounts for 0.08% of the portfolio, ranked #128.

Argyle Capital Management first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $316K in Q1 2025. 881 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Argyle Capital Management held 3,527 shares of Solventum worth $272K as of Q2 2026.
  • Argyle Capital Management sold 12 Solventum shares in Q2 2026, an estimated $875.
  • Solventum made up 0.08% of Argyle Capital Management's portfolio in Q2 2026, its #128 holding.
  • Argyle Capital Management first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Argyle Capital Management's Solventum position peaked at $316K in Q1 2025.
  • 881 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Argyle Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.